QA: Rezolute Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2016_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc

  xvar xval
0 AssetsCurrent 6,116,384
1 IntangibleAssetsNetIncludingGoodwill 58,906
2 PropertyPlantAndEquipmentNet 4,524,912
3 remainder_Assets 563,000
4 LiabilitiesCurrent 1,705,778
5 LiabilitiesNoncurrent 503,617
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,996,673
9 ResearchAndDevelopmentExpense 4,701,209
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -664,482
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,263,202
1 Liabilities 2,209,395
2 Expenses 10,697,882
3 Revenues 0
4 StockholdersEquity 9,053,807
5 NetIncome -11,362,364
6 ComprehensiveNetIncome -11,362,364
7 BaseVar 12,417,480
8 EconomicCapitalRatiobeforeLimitedLiability 1.24
9 EconomicCapitalRatio 2.49

Edgar->Model Mapping

Feature Distribution

Change over Time